[Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide].
Sitbon Sitruk
L
L
Unité fonctionnelle de biologie de la reproduction, groupe hospitalier Pitié-Salpêtrière, université Paris VI, 47-83, boulevard de l'Hôpital, 75013 Paris, France. lesliesitbon@hotmail.com
Sanson
M
M
Prades
M
M
Lefebvre
G
G
Schubert
B
B
Poirot
C
C
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D015925:Cryopreservation; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004622:Embryo, Mammalian; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced* / Q000517:prevention & control; D009865:Oocytes; D011247:Pregnancy; D011256:Pregnancy Outcome; D027724:Reproductive Techniques, Assisted; D012189:Retrospective Studies; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide
Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité : exemple du témozolomide.